bpc-157 transdermal patch A new painless developed by researchers at JAX in collaboration with the Massachusetts Institute of Technology (MIT) offers new way to monitor immune health., The first of its kind bandage-like BPC-157/NAD+/GUK-Cu - Peptide Patch -

As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology

This conclusion was also reached in another study (5)

The standard protocol uses 2.8 mg per injection: 2 mg GHK-Cu + 400 mcg of BPC-157 + 400 mcg of TB-4

They include the following: Vegetarians, vegans and people eating macrobiotic diets

Once peptides have been received, it is imperative that they are kept cold and away from light